Unlocking the value in DATA. Summer 04 By Dr Amber Salzman In recent years enormous sums have been spent on systems and data management, but are we getting full value from these investments? We discuss here how organisations, scientists and, inde... Read more...

the current BIOINFORMATICS analytical software landscape. Summer 04 By Charles Chang With the vast amount of biochemical data generated from experiments conducted by research laboratories around the globe, there is strong demand for software to analyse and manage the data... Read more...

Collaborative eR&D. Spring 04 By Richard O’Rourke In 2001 at the GlaxoSmithKline inaugural shareholder meeting, Chief Executive JP Garnier was clearly not happy with what he regarded as the ‘productivity crisis’ within the industryâ€... Read more...

Making the most of your discovery data. Spring 04 By Dr Nick Davies and Dr Tim Peakman Discovery scientists in most pharmaceutical companies are struggling with incompatible legacy systems, a growing volume of data and the imminent advent of a product model that will demand... Read more...

Role of image informatics in accelerating drug discovery and development. Winter 2003 By Robert Dunkle There is a new category of informatics that is proving itself essential to the acceleration of drug discovery and development. Image informatics is the systematic use of image data as a m... Read more...

in silico structure-based drug design – SHIFTING THE BOTTLENECK? Spring 2003 By Dr Jonathan Heal Drug Discovery The use of in silico methods in drug design has grown significantly in popularity over the past couple of years. Indeed many pharma companies have already adopted some type of virtual scr... Read more...